Daewoong Pharmaceutical Co. LTD.   Report issue

Founded: Seoul Korea, Republic of (1942)

Organization Overview

First Clinical Trial
2003
NCT02693522
First Marketed Drug
2015
meropenem (merrem)
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Daewoong Pharmaceutical Co. LTD. | DAEWOONG PHARM CO